Accumulation of Nuclear p53 and Tumor Progression in Bladder Cancer

New England Journal of Medicine

Volumn 331, Issue 19, 1994, Pages 1259-1264

  Esrig, David ^a   Elmajian, Donald ^a   Groshen, Susan ^a   Freeman, John A ^a   Stein, John P ^a   Chen, Su Chiu ^a   Nichols, Peter W ^a   Skinner, Donald G ^a   Jones, Peter A ^a   Cote, Richard J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CYSTECTOMY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0028051625     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199411103311903     Document Type: Article

References (23)

1. Hollstein M, Sidransky D, Vogelstein B, Harris CC p53 Mutations in human cancers. Science 1991; 253: 49-53
2. Lane DP Cancer: p53, guardian of the genome. Nature 1992; 358: 15-16
3. Sidransky D, Von Eschenbach A, Tsai YC, Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991; 252: 706-709
4. Spruck CH III, Ohneseit PF, Gonzalez-Zulueta M, Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994; 54: 784-788
5. Esrig D, Spruck CH III, Nichols PW, p53 Nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 1993; 143: 1389-1397
6. Sarkis AS, Zhang Z, Cordon-Cardo C, p53 Nuclear overexpression and disease progression in Ta bladder carcinoma. Int J Oncol 1993; 3: 355-360
7. Sidransky D, Messing E Molecular genetics and biochemical mechanisms in bladder cancer: oncogenes, tumor suppressor genes, and growth factors. Urol Clin North Am 1992; 19: 629-639
8. Cordon-Cardo C, Wartinger D, Petrylak D, Altered expression of retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst 1992; 84: 1251-1256
9. Logothetis CJ, Xu HJ, Ro JY, Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 1992; 84: 1256-1261
10. Skinner DG Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 1982; 128: 34-36
11. Skinner DG, Daniels JR, Russell CA, The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991; 145: 459-467
12. Stockle M, Meyenburg W, Wellek S, Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy: results of a controlled prospective study. J Urol 1992; 148: 302-307
13. Sarkis AS, Dalbagni G, Cordon-Cardo C, Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 1993; 85: 53-59
14. Lipponen PK Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int J Cancer 1993; 53: 365-370
15. Bergkvist A, Ljungqvist A, Moberger G Classification of bladder tumours based on the cellular pattern. Acta Chir Scand 1965; 130: 371-378
16. Hermanek P, Sobin LH, eds. TNM classification of malignant tumors. 4th ed. New York: Springer-Verlag, 1987:133-4.
17. Fienberg SE. The analysis of cross-classified categorical data. Cambridge, Mass.: MIT Press, 1977:9-86.
18. Kaplan EL, Meier P Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481
19. Miller RG Jr. Survival analysis. New York: John Wiley, 1981:44-102.
20. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine MJ Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 1988; 8: 531-539
21. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358: 80-83
22. Cordon-Cardo C, Latres E, Drobjnak M, Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994; 54: 794-799
23. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-6311